Impact of the COVID-19 pandemic on interventional cardiology activity in Spain
Impact of the COVID-19 pandemic on interventional cardiology activity in Spain
复制标题
DOI：
10.24875/recice.m20000123
复制
发表时间：
2020-04-01
期刊：
影响因子：
--
通讯作者：
Moreno, Raul
中科院分区：
文献类型：
--
作者：
Rodriguez-Leor, Oriol;Cid-Alvarez, Belen;Moreno, Raul
导读与目的：2019冠状病毒病（COVID-19）疫情和国家宣布进入警戒状态导致介入心脏科医疗活动减少。本研究的目的是量化这些活动的变化，特别关注st段抬高型心肌梗死（STEMI）患者的治疗。方法：对西班牙17个自治区81个参与STEMI网络的中心进行远程信息调查。收集STEMI的诊断活动、经皮冠状动脉介入治疗（PCI）、结构性干预和PCI、STEMI网络组织的变化以及介入心脏病专家中COVID-19的流行情况等信息。比较了2月24日至3月1日（疫情爆发前）一周和3月16日至3月22日（疫情爆发期间）一周的数据。结果：73个中心（90%）获得应答。在STEMI中，诊断程序（-56%）、PCI（-48%）、结构性干预（-81%）和PCI（-40%）的数量显著减少。尽管初级血管成形术仍然是主要的再灌注策略，但据报道，药物溶栓的使用略有增加。高达5%的介入心脏病专家（17人）患有COVID-19。结论：在2019冠状病毒病流行期间，介入心脏病学活动显著减少。同样，在STEMI网络中治疗的患者数量大幅减少，这意味着发病率和死亡率增加的风险。科学学会和卫生当局必须促进出现STEMI相容症状的患者立即进入卫生系统，以适当的方式接受再灌注治疗。
Introduction and objectives: The COVID-19 epidemic and the declaration of the state of alarm have led to a decrease in healthcare activity in interventional cardiology units. The objective of this study is to quantify these changes in activity, with special interest in the treatment of patients with ST-segment elevation myocardial infarction (STEMI). Methods: A telematic survey of 81 centers involved in STEMI networks in the 17 autonomous communities of Spain. Information was collected on diagnostic activity, percutaneous coronary intervention (PCI), structural interventions, and PCI in STEMI on changes in the organization of STEMI networks, and on the prevalence of COVID-19 among interventional cardiologists. Data was compared for the week of February 24 through March 1 (before the outbreak) and for the week of March 16 through March 22 (during the outbreak). Results: Response has been obtained from 73 centers (90%). A very significant decrease in the number of diagnostic procedures (-56%), PCI (-48%), structural interventions (-81%) and PCI in STEMI (-40%) has been observed. A slight increase in the use of pharmacological thrombolysis has been reported, although primary angioplasty remains the leading reperfusion strategy. Up to 5% of interventional cardiologists ( 17) had COVID-19. Conclusions: An important reduction in the activity in interventional cardiology has been observed during the COVID-19 epidemic. Likewise, a great decrease has been detected in the number of patients treated in the STEMI networks, with the risk of increased morbidity and mortality that this represents. Scientific societies and health authorities have to promote that patients presenting STEMI compatible symptoms proceed with no delay to access the health system to receive reperfusion treatment in an appropriate way.